Adoptive immunotherapy for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10858626
APP PUB NO 20170349880A1
SERIAL NO

15536258

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be used in adoptive immunotherapy in cancer treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE LAUSANNERUE DU BUGNON 21 LAUSANNE 1011 SWITZERLAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crespo, Isaac Lausanne, CH 1 44
Doucey, Marie-Agnes Lausanne, CH 7 44
Guex, Nicolas Lausanne, CH 2 51
Xenarios, Ioannis Lausanne, CH 2 44

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 8, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00